You searched for Antibody candidate - Page 35 of 69

News and Trends 15 Nov 2022

Aelis Farma’s first trial for cognitive disorder drug for Down Syndrome patients

…candidate for the treatment of cognitive disorders. Aelis Farma is a clinical stage biopharmaceutical company specializing in the development of treatments for brain diseases, made the announcement today (November 15)….

November 15, 2022 - 4 minutesmins - By Liza Laws

News and Trends 7 Feb 2023

AAHI bags $9.9M to develop nasal spray influenza RNA vaccine

…develop a prototype intranasal bivalent influenza RNA vaccine candidate. The candidate will be based on AAHI’s self-amplifying RNA (saRNA) platform, which targets both pandemic A(H5N1) and A(H7N9) influenza virus pathogens….

February 7, 2023 - 3 minutesmins - By Jim Cornall

In Depth 9 Dec 2024

CAR-T cell therapy for lupus: An emerging field with great potential

…bring this type of therapy to the market, potentially offering a cure for the disease. So far, though, candidates are still working their way through the clinic trials, and a…

December 9, 2024 - 10 minutesmins - By Willow Shah-Neville

News and Trends 4 Jan 2023

Infex’s novel AMR drug candidate MET-X receives FDA QIDP designation

Infex Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted qualified infectious disease product (QIDP) designation to MET-X, the company’s broad spectrum metallo-beta-lactamase (MBL) inhibitor. Infex…

January 4, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 18 Apr 2024

5 RNA editing companies you should know about

…rare and common diseases. It is currently working on advancing its first therapeutic program, a best-in-class product candidate to treat the inherited genetic disease alpha-1 antitrypsin deficiency (AATD), as well…

April 18, 2024 - 7 minutesmins - By Willow Shah-Neville

More News! 8 Feb 2017

The First Stroke Drug in Decades? French Biotech gets closer to the Clinic

…Medicine & Healthcare products Regulatory Agency (MHRA) received in January. Acticor’s candidate, ACT017, is a humanized antibody fragment (Fab) that inhibits the activity of platelet glycoprotein VI (GPVI). This strategy…

February 8, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Jan 2020

Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas

The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese Astellas Pharma to complete phase I trials of candidate off-the-shelf T-cell therapies for cancer including…

January 15, 2020 - 2 minutesmins - By Jonathan Smith

abivax ceo ehrlich interview hiv hepatitis

News and Trends 4 Jul 2016

“We have one of the World’s Most Advanced Functional HIV Cures under development”

…its CMO Jean-Marc Steens… Abivax is one of the high-profile Biotechs in Paris. With a pipeline with candidates for hepatitis B and HIV, it raised €57M during its IPO on…

July 4, 2016 - 5 minutesmins - By Denise Neves Gameiro

heptares allergan neurological alzheimer gpcr

News and Trends 7 Apr 2016

Allergan Signs Massive €3Bn Alzheimer’s Deal with UK Biotech

Heptares Therapeutics is licensing its portfolio of novel candidates for neurological diseases, including one for Alzheimer’s, to Allergan for up to €3Bn. A good way for Allergan to ‘get over’…

April 7, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 23 Jan 2018

Swedish Biotech Can Now Fast-Track its Metabolic Disorder Drug

…addition, the company’s candidate has received Fast Track status from the FDA, which will help the candidate move into the clinic in 2018. Sanfilippo A syndrome is a life-threatening inherited…

January 23, 2018 - 2 minutesmins - By Alex Dale

In Depth 12 Feb 2024

RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?

…its RNA editing candidate, WVE-006. This was accepted, and dosing for that trial has now begun in the U.K., marking the first time an RNA editing candidate has reached the…

February 12, 2024 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 16 Nov 2022

Six biotech stocks trading below cash right now

…result, Atea plans to test its lead candidate antiviral in a phase 3 trial by the end of 2022. The trial will recruit at least 1,500 high-risk, non-hospitalized patients with…

November 16, 2022 - 6 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Aelis Farma’s first trial for cognitive disorder drug for Down Syndrome patients

AAHI bags $9.9M to develop nasal spray influenza RNA vaccine

CAR-T cell therapy for lupus: An emerging field with great potential

Infex’s novel AMR drug candidate MET-X receives FDA QIDP designation

5 RNA editing companies you should know about

The First Stroke Drug in Decades? French Biotech gets closer to the Clinic

Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas

“We have one of the World’s Most Advanced Functional HIV Cures under development”

Allergan Signs Massive €3Bn Alzheimer’s Deal with UK Biotech

Swedish Biotech Can Now Fast-Track its Metabolic Disorder Drug

RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?

Six biotech stocks trading below cash right now

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!